Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstract Directory, Friday, May 17, 2013<br />
Poster Session II, continued<br />
5:30 PM - 7:30 PM<br />
Room: Exhibit Hall C/D<br />
Cancer Immunotherapy II<br />
392<br />
Restored Expression <strong>of</strong> Heparanase in Tumor<br />
Speciic T <strong>Cell</strong>s Enhances Their Antitumor Effects in<br />
Neuroblastoma<br />
Ignazio Caruana, Valentina Hoyos, Gerrit Weber, Barbara Savoldo,<br />
Dario Marchetti, Gianpietro Dotti.<br />
393<br />
Single-<strong>Cell</strong> Imaging Reveals That Subsets <strong>of</strong> T <strong>Cell</strong>s<br />
Expressing a CD19-Speciic Chimeric Antigen Receptor<br />
Differ in Effector Function<br />
Harjeet Singh, Ivan Liadi, Gabrielle Romain, Navin Varadarajan,<br />
Laurence J. N. Cooper.<br />
394<br />
MCSP-Chimeric Antigen Receptor (CAR)-Redirected T<br />
<strong>Cell</strong>s Target Multiple Solid Tumors<br />
Claudia Arambula, Barbara Savoldo, Valentina Hoyos, Eric Yvon,<br />
Michele Del Vecchio, Soldano Ferrone, Gianpietro Dotti.<br />
395<br />
Tumor Recurrences Share Immunogenic Antigens<br />
across Both Tumor Types and Primary Treatments<br />
Which Can Be Therapeutically Targeted with VSV-cDNA<br />
Libraries<br />
Nicolas Boisgerault, Jose Pulido, Timothy Kottke, Oliver Donnelly,<br />
Esteban Celis, Jill Thompson, Rosa Diaz, Kevin Harrington, Hardev<br />
Pandha, Peter Selby, Alan Melcher, Richard Vile.<br />
396<br />
BARF1-Speciic T <strong>Cell</strong>s for the Adoptive Immunotherapy<br />
<strong>of</strong> EBV-Positive Nasopharyngeal Carcinoma<br />
Mamta Kalra, Minhtran C. Ngo, Ulrike Gerdemann, Ann Leen,<br />
Chrystal Louis, Cliona M. Rooney, Stephen Gottschalk.<br />
397<br />
IL-12 Increases Immune Responses Induced by a Novel<br />
pDNA Prostate Cancer Immunotherapy Approach in<br />
Non-Human Primates<br />
Bernadette Ferraro, Amritha Balakrishnan, Jewell N. Walters,<br />
Devin J. Myles, Jian Yan, Amir S. Khan, Niranjan Y. Sardesai, David<br />
B. Weiner.<br />
398<br />
Transgenic Expression <strong>of</strong> a Novel Immunosuppressive<br />
Signal Converter on T <strong>Cell</strong>s<br />
Norihiro Watanabe, Usanarat Anurathapan, Malcolm K. Brenner,<br />
Helen E. Heslop, Ann M. Leen, Cliona M. Rooney, Juan F. Vera.<br />
399<br />
Hypomethylating Agent 5-aza Cytidine Exposure To<br />
Improve AP1903 Treatment for Apoptosis Induction <strong>of</strong><br />
iCasp9/DCD19 <strong>Gene</strong> Modiied T <strong>Cell</strong>s<br />
Elodie Bole-Richard, Jean-Marie Certoux, Idir Idirene, Laurent<br />
Jossot, Eric Deconinck, Fabrice Larosa, Etienne Daguindau,<br />
Christophe Borg, Pierre Tiberghien, Christophe Ferrand, Marina<br />
Deschamps.<br />
400<br />
Adapting the Spontaneous Canine Osteosarcoma Model<br />
for T-<strong>Cell</strong> <strong>Therapy</strong><br />
Melinda Mata, Sunitha Kakarla, Juan Vera, Lisa Wang, Cliona<br />
Rooney, Heather Wilson, Stephen Gottschalk.<br />
401<br />
T-<strong>Cell</strong> Engineering for Adoptive Immunotherapy Using<br />
TAL-Effector Nucleases (TALENTM)<br />
Laurent Poirot Poirot, Cécile Schiffer-Mannioui, Agnes Gouble,<br />
Roman Galetto, Stephanie Grosse, Isabelle Chion-Sotinel, Diane Le<br />
Clerre, Laetitia Lemaire, Céline Lebuhotel, Justin Eyquem, Sylvain<br />
Arnould, Julianne Smith, Andrew Scharenberg, Sophie Derniame.<br />
402<br />
Randomized Phase II Trial <strong>of</strong> Post-Operative Adjuvant<br />
Chemotherapy ±FANG Autologous Tumor <strong>Cell</strong> Vaccine<br />
in Colorectal Carcinoma with Liver Metastases<br />
Joseph Kuhn, Neil Senzer, Minal Barve, G. Thomas Shires,<br />
Padmasini Kumar, Donald D. Rao, Gladice Wallraven, Beena O.<br />
Pappen, Phillip B. Maples, John Nemunaitis.<br />
403<br />
The Potential <strong>of</strong> Pro-Apoptotic PAC-1 Treatment<br />
for Augmentation <strong>of</strong> IL-2 Mediated Breast Cancer<br />
Immunotherapy<br />
Shyambabu Chaurasiya, Paggy Hew, Paul J. Hergenrother, David<br />
Sharon, Mary Hitt.<br />
404<br />
Effect <strong>of</strong> IL-15 <strong>Gene</strong> <strong>Therapy</strong> and mTOR Inhibitor<br />
Everolimus on Experimental Metastatic Breast Cancer<br />
Growth<br />
Na Zhao, Xiaodan Li, Feng Qi, Yujie Qiu, Xianghui He, Liwei Zhu.<br />
Cancer-Oncolytic Viruses I<br />
405<br />
Measles Virus for Immunovirotherapy <strong>of</strong> Cancer<br />
Christian Grossardt, Christine E. Engeland, Sascha Bossow, Silke<br />
Hamzaoui-Nord, Niels Halama, Dirk Jäger, Christ<strong>of</strong> von Kalle, Guy<br />
Ungerechts.<br />
406<br />
Oncolytic Herpes Simplex Viruses Encoding an<br />
Antibody Retargeted C5a Complement Protein for<br />
Multiple Myeloma <strong>Therapy</strong><br />
Hongtao Li, Stephen J. Russell.<br />
Friday, May 17, 2013<br />
407<br />
Mengovirus <strong>Therapy</strong> for Multiple Myeloma<br />
Autumn Ruiz, Elizabeth M. Hadac, Stephen J. Russell.<br />
<strong>Final</strong> <strong>Program</strong> SALT LAKE CITY, UTAH May 15–18, 2013<br />
117
Change language